Jefferies Maintains Buy on BELLUS Health, Raises Price Target to $21

Jefferies analyst Suji Jeong maintains BELLUS Health (NASDAQ:BLU) with a Buy and raises the price target from $14 to $21.

Jefferies analyst Suji Jeong maintains BELLUS Health (NASDAQ:BLU) with a Buy and raises the price target from $14 to $21.

Total
0
Shares
Related Posts